Swiss pharmaceutical company Novartis has filed a lawsuit against President Joe Biden's administration over a disagreement regarding the 340B Drug Discount Program. The company claims that the U.S. Health Resources and Services Administration interpreted a federal law wrongly, preventing Novartis from changing payment terms for participating hospitals. This move by Novartis could have significant repercussions on the negotiation process for the company's popular heart drug, Entresto, and its pricing under Medicare. Stay updated on market-moving news with TheFly and check out top-performing stocks on TipRanks.
Novartis Sues Biden Administration Over 340B Drug Discount Program
Swiss pharmaceutical giant Novartis has filed a lawsuit against the Biden administration over a disagreement regarding the 340B Drug Discount Program. The company claims that the U.S. Health Resources and Services Administration (HRSA) interpreted a federal law wrongly, preventing Novartis from changing payment terms for participating hospitals.
The 340B Drug Discount Program is a federal program that was established in 1992 to provide discounted prescription drugs to low-income and uninsured patients. Hospitals that participate in the program are required to pass along the discounts they receive from drug manufacturers to patients.
Novartis argues that the HRSA has misinterpreted the 340B law by requiring drug manufacturers to provide discounts to hospitals regardless of whether the drugs are actually used to treat low-income or uninsured patients. The company says that this interpretation of the law has led to "significant overpayments" to hospitals and that it has been forced to subsidize the program with its own profits.
The lawsuit could have significant repercussions on the negotiation process for Novartis's popular heart drug, Entresto. The drug is currently covered under Medicare Part D, and Novartis is seeking to change the payment terms for Entresto in order to increase its profits. The lawsuit could delay or prevent Novartis from making these changes, which could impact the price of Entresto for Medicare beneficiaries.
Background
The 340B Drug Discount Program was created as part of the Omnibus Budget Reconciliation Act of 1990. The program was originally designed to help hospitals that serve a disproportionate share of low-income and uninsured patients. The program has since been expanded to include a wider range of hospitals, including many that do not serve a disproportionate share of low-income and uninsured patients.
In 2010, the Affordable Care Act made significant changes to the 340B program. The changes included adding new eligibility requirements for hospitals and increasing the discounts that drug manufacturers are required to provide.
Top 5 FAQs
1. What is the 340B Drug Discount Program?
The 340B Drug Discount Program is a federal program that requires drug manufacturers to provide discounts to hospitals that serve a disproportionate share of low-income and uninsured patients. The program is designed to help these hospitals provide affordable prescription drugs to their patients.
2. What is Novartis's lawsuit about?
Novartis is suing the Biden administration over the HRSA's interpretation of the 340B law. Novartis argues that the HRSA is requiring drug manufacturers to provide discounts to hospitals regardless of whether the drugs are actually used to treat low-income or uninsured patients.
3. What could the lawsuit mean for Novartis?
The lawsuit could delay or prevent Novartis from making changes to the payment terms for its popular heart drug, Entresto. This could impact the price of Entresto for Medicare beneficiaries.
4. What could the lawsuit mean for the 340B program?
The lawsuit could have a significant impact on the 340B program. If Novartis is successful in its lawsuit, it could lead to changes in the way that the program is administered. This could make it more difficult for hospitals to participate in the program or could reduce the discounts that hospitals receive from drug manufacturers.
5. What is the future of the 340B program?
The future of the 340B program is uncertain. The program has been the subject of ongoing debate, with some stakeholders arguing that it is too costly and that it does not effectively target low-income and uninsured patients. However, the program remains popular with hospitals and patient advocates, and it is likely to continue to be a source of controversy in the years to come.
Blackstone, a major asset manager, has announced plans to invest $1.2 billion in building a new power plant in West Virginia to meet surging electricity demand from artificial intelligence and industrial growth. The 600-megawatt plant will be funded by utilities and large investors, and will supply power to Old Dominion Electric Cooperative, serving 1.5 million residents. Blackstone's senior managing director says the investment aligns with their focus on meeting the increasing demand for electricity from AI and other industries. This is just the latest in Blackstone's recent energy investments, totaling over 1,600 megawatts of new gas-fired capacity.
Efforts to ease tensions between Pakistan and Afghanistan came to a standstill during peace talks in Istanbul, with both sides pointing fingers at each other for the breakdown. In a press conference, Afghan delegation leader Mullah Najib shared that Pakistan demanded a fatwa against the Tehreek-e-Taliban Pakistan (TTP) from the Taliban's Supreme Leader. He stated that such a decision should be made by the Dar al-Ifta, a religious authority in Afghanistan, in response to a written request from Pakistan's government. This comes as Pakistan has repeatedly accused Afghanistan's Taliban rulers of supporting the TTP, a militant group responsible for attacks inside Pakistan.
After months of anticipation and restructuring, Tata Motors Commercial Vehicles Ltd (TMCVL) is finally set to debut on the Indian stock exchanges today. As part of the demerger process, the commercial vehicle (CV) business has now been renamed Tata Motors and will operate as a separate entity. Experts are expecting a strong debut for the company's shares, with a potential listing price range of Rs 300-350 per share. Investors will have to exercise caution, as the stock will initially be in the trade-for-trade segment to ensure smooth price discovery.
Indian equity benchmark indices, the Sensex and Nifty, started the session in the green on Wednesday with a significant increase backed by positive global cues. Shares of the commercial vehicle business of Tata Motors will start trading today after their debut on the bourses. With major players like Eternal and Bajaj Finserv leading the pack, the markets saw a mixed response from different sectors. Foreign Institutional Investors offloaded equities while Domestic Institutional Investors bought stocks, shaping market trends for the day. Broader Asian equities and the US markets also showed mixed signs.
Economic Offences Wing conducts raids on an assistant manager of Primary Agricultural Credit Co-operative Society in Madhya Pradesh and uncovers movable and immovable assets worth crores of rupees. The EOW had received a complaint regarding alleged corruption by the manager, leading to the registration of an FIR. The team finds that the manager acquired these assets in his and his family members' names in the past 10 years, despite only receiving a salary of Rs 50 lakh in his 15 years of service. Investigation is ongoing into the purchase of bank accounts, lockers, and agricultural land by the manager.
The Deputy Commissioner of Pulwama, Dr. Basharat Qayoom, recently chaired a review meeting to assess the progress of the PM Surya Ghar Muft Bijli Yojana in the district. Detailed presentations were given on the achievements and current status of the scheme, with a focus on expediting the installation of rooftop solar systems and streamlining the bank loan process. The importance of active coordination between KPDCL, vendors, and banking partners was emphasized, along with the need for a public outreach campaign to promote the long-term benefits of the initiative.
The Bheem Bhai Tribal Women's Cooperative Society in Utnoor is revolutionizing the idea of women's economic empowerment by producing high-quality and nutritious Ipappuvvu laddus, a traditional delicacy made from locally sourced ingredients. With an annual turnover of Rs.1.27 crore, the society not only benefits 100 tribal families but also supplies laddus to 77 tribal residential schools and sells them in the open market. The success of the cooperative has been recognized by Minister Danasari Anasuya and Prime Minister Narendra Modi, highlighting the impact of women-led economic transformation in tribal areas.
TTD's Additional Executive Officer, Ch Venkaiah Chowdary, conducted a meeting to review feedback from devotees regarding various amenities provided by TTD in Tirumala. The meeting included discussions on queue management, food services, sanitation, and price control. The TTD also introduced a potential parking solution, presented by Gopark Technology Private Limited, to make parking in Tirumala more efficient and convenient for devotees.
The Securities and Exchange Board of India (SEBI) has cautioned investors against investing in digital or e-gold products, which fall outside its regulatory framework. The regulator clarified that such products are not notified as securities or regulated as commodity derivatives, and therefore do not have the same investor protection mechanisms in place. SEBI recommends investing in regulated gold products, such as Gold Exchange Traded Funds (ETFs) and Electronic Gold Receipts, which are governed by its regulatory framework and can be accessed through registered intermediaries.
In a review meeting held at the SPRH meeting hall in Tirumala, TTD's additional executive officer, Ch. Venkaiah Chowdary, examined pilgrim feedback on various amenities and services. Acting on the Chief Minister's directive, TTD has been collecting feedback through multiple channels and Chowdary stressed the importance of implementing suggestions for continuous improvement. The meeting also saw a presentation from Gopark Technology Pvt Ltd on a smart parking management proposal aimed at reducing congestion.